Drug
GB 0895
GB 0895: highest development phase Phase 3, developed by Generate Biomedicines. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Generate Biomedicines
Trials
| Drug | Phase | Indication |
|---|---|---|
| GB-0895 NCT07276724 | Phase 3 | Severe Asthma |
Latest
No recent events.
Follow GB 0895 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.